StockData
Journey Medical Corp logo

Journey Medical Corp (DERM) stock

DERMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3033% below fair value
$3.69−0.21 (-5.38%)

Close on Nov 18, 2026Market cap $104.15MP/E –Yield –

Journey Medical pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Journey Medical's pe ratio was 135.5× on Oct 31, 2024.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Oct 31, 2024135.5×–

More Journey Medical figures

See a number that looks wrong?